|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.04 USD | -0.04% |
|
+7.14% | -51.71% |
| 07-30 | Health Care Down After Mixed Earnings - Health Care Roundup | DJ |
| 07-29 | Piper Sandler Adjusts Price Target on Boston Scientific to $60 From $65 | MT |
| Market Cap | 68.43B 60.13B 56.13B 51.51B 96.42B 6,555B 98.8B 666B 260B 3,244B 257B 251B 11,213B | P/E 2026 * |
16.7x | P/E 2027 * | 16.8x |
|---|---|---|---|---|---|
| Enterprise Value | 74.81B 65.73B 61.36B 56.31B 105B 7,165B 108B 728B 285B 3,546B 281B 275B 12,258B | EV / Sales 2026 * |
3.51x | EV / Sales 2027 * | 3.14x |
| Free-Float |
84.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | -0.30% | ||
| 1 week | +7.14% | ||
| Current month | +7.87% | ||
| 1 month | +5.89% | ||
| 3 months | -19.44% | ||
| 6 months | -50.14% | ||
| Current year | -51.71% |
| 1 week | 42.55 |  | 47.16 |
| 1 month | 42.2 | | 47.16 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 A | Fiscal year | Chief Financial Officer | 5,184 | 0.0004% | ||
| 5/28/26 A | Don | Chief Executive Officer | -386,755 | 0.0261% | ||
| 5/20/26 A | Buy | Director | 1,770 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | +7.14% | -56.76% | -10.93% | 68.43B | |
| +0.01% | +9.50% | +19.56% | +2.60% | 214B | |
| -1.29% | +9.69% | -5.01% | -24.45% | 138B | |
| -2.40% | +3.64% | -28.94% | +8.14% | 125B | |
| +2.49% | +1.65% | +6.57% | +2.41% | 49.38B | |
| -0.81% | +9.46% | -24.73% | -29.48% | 47.55B | |
| -0.17% | +5.13% | +17.07% | +11.31% | 39.63B | |
| -1.15% | +2.34% | +25.16% | +32.79% | 37.26B | |
| +12.15% | +17.08% | -7.49% | -7.67% | 32.71B | |
| +2.55% | +11.08% | -22.83% | -3.98% | 30.91B | |
| Average | +1.13% | +7.51% | -7.74% | -1.93% | 78.3B | |
| Weighted average by Cap. | +0.03% | +7.67% | -5.34% | -3.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.31B 18.72B 17.48B 16.04B 30.03B 2,041B 30.77B 207B 81.05B 1,010B 80B 78.27B 3,491B | 22.79B 20.03B 18.69B 17.16B 32.12B 2,183B 32.91B 222B 86.69B 1,080B 85.57B 83.71B 3,735B |
| Net income | 3.71B 3.26B 3.05B 2.8B 5.23B 356B 5.36B 36.12B 14.13B 176B 13.95B 13.64B 609B | 3.95B 3.47B 3.24B 2.97B 5.56B 378B 5.7B 38.4B 15.02B 187B 14.82B 14.5B 647B |
| Net Debt | 6.38B 5.6B 5.23B 4.8B 8.99B 611B 9.21B 62.02B 24.25B 302B 23.94B 23.42B 1,045B | 3.17B 2.78B 2.6B 2.38B 4.46B 303B 4.57B 30.81B 12.05B 150B 11.89B 11.63B 519B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | $46.04 | -0.04% | 51,286,660 |
| 28/07/26 | $46.06 | +1.21% | 26,905,670 |
| 27/07/26 | $45.51 | +2.85% | 20,044,682 |
| 24/07/26 | $44.25 | +1.54% | 20,689,854 |
| 23/07/26 | $43.58 | +1.42% | 16,535,740 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
